Your browser doesn't support javascript.
loading
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors.
Pekkarinen, Meeri; Nordfors, Kristiina; Uusi-Mäkelä, Joonas; Kytölä, Ville; Hartewig, Anja; Huhtala, Laura; Rauhala, Minna; Urhonen, Henna; Häyrynen, Sergei; Afyounian, Ebrahim; Yli-Harja, Olli; Zhang, Wei; Helen, Pauli; Lohi, Olli; Haapasalo, Hannu; Haapasalo, Joonas; Nykter, Matti; Kesseli, Juha; Rautajoki, Kirsi J.
Afiliación
  • Pekkarinen M; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Nordfors K; https://ror.org/033003e23 Tampere Center for Child Health Research, Tays Cancer Center, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Uusi-Mäkelä J; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Kytölä V; Unit of Pediatric Hematology and Oncology, Tampere University Hospital, Tampere, Finland.
  • Hartewig A; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Huhtala L; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Rauhala M; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Urhonen H; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Häyrynen S; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Afyounian E; https://ror.org/033003e23 Department of Neurosurgery, Tays Cancer Centre, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Yli-Harja O; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Zhang W; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Helen P; https://ror.org/033003e23 Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Lohi O; https://ror.org/033003e23 Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Haapasalo H; Institute for Systems Biology, Seattle, WA, USA.
  • Haapasalo J; Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
  • Nykter M; https://ror.org/033003e23 Department of Neurosurgery, Tays Cancer Centre, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Kesseli J; https://ror.org/033003e23 Tampere Center for Child Health Research, Tays Cancer Center, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Rautajoki KJ; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
Life Sci Alliance ; 7(6)2024 Jun.
Article en En | MEDLINE | ID: mdl-38499326
ABSTRACT
Atypical teratoid/rhabdoid tumors (AT/RTs) are pediatric brain tumors known for their aggressiveness and aberrant but still unresolved epigenetic regulation. To better understand their malignancy, we investigated how AT/RT-specific DNA hypermethylation was associated with gene expression and altered transcription factor binding and how it is linked to upstream regulation. Medulloblastomas, choroid plexus tumors, pluripotent stem cells, and fetal brain were used as references. A part of the genomic regions, which were hypermethylated in AT/RTs similarly as in pluripotent stem cells and demethylated in the fetal brain, were targeted by neural transcriptional regulators. AT/RT-unique DNA hypermethylation was associated with polycomb repressive complex 2 and linked to suppressed genes with a role in neural development and tumorigenesis. Activity of the several NEUROG/NEUROD pioneer factors, which are unable to bind to methylated DNA, was compromised via the suppressed expression or DNA hypermethylation of their target sites, which was also experimentally validated for NEUROD1 in medulloblastomas and AT/RT samples. These results highlight and characterize the role of DNA hypermethylation in AT/RT malignancy and halted neural cell differentiation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cerebelosas / Tumor Rabdoide / Meduloblastoma Límite: Child / Humans Idioma: En Revista: Life Sci Alliance Año: 2024 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cerebelosas / Tumor Rabdoide / Meduloblastoma Límite: Child / Humans Idioma: En Revista: Life Sci Alliance Año: 2024 Tipo del documento: Article País de afiliación: Finlandia